re: Ann: Strategic milestone underpins US rev... Now surely a company generating over $30m in global sales , spends $5m a year in R&D and has just realeased a number of new products is worth much more than $15m
Net debt is almost zero and cashflow supports its growth also if the business were sold it would go for 1.5 to 2 times sales.
We could compare them with numerous other medical device companies who have similar market caps but have virtually no sales and need capital.
re: Ann: Strategic milestone underpins US rev... Now surely a...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $56.70M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 22900 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 200000 | 1 |
View Market Depth
| Last trade - 16.21pm 25/07/2025 (20 minute delay) ? |
| CMP (ASX) Chart |
Day chart unavailable